Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X

A Di Monaco1, I Bruno, A Sestito

  • 1Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Roma, Italy.

Insights

Cardiac MIBG uptake abnormalities and coronary microvascular dysfunction are common in cardiac syndrome X (CSX). However, this study found no correlation between these cardiac MIBG defects and impaired coronary flow response in CSX patients.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Cardiovascular Imaging

Background:

  • Cardiac Syndrome X (CSX) is characterized by chest pain despite normal coronary angiograms.
  • Coronary microvascular dysfunction (CMD) is increasingly recognized as a key feature of CSX.
  • The role of cardiac autonomic dysfunction in CSX is not fully understood.

Purpose of the Study:

  • To investigate the relationship between cardiac adrenergic nerve function, assessed by (123)I-metaiodobenzylguanidine (MIBG) scintigraphy, and coronary microvascular dysfunction in patients with CSX.
  • To determine if MIBG uptake abnormalities correlate with impaired coronary flow reserve in CSX.

Main Methods:

  • A case-control study involving 29 patients with CSX and 20 healthy controls.
  • Myocardial scintigraphy using (123)I-metaiodobenzylguanidine (MIBG) planar and SPECT imaging.
  • Coronary flow response (CFR) to adenosine and cold pressor test (CPT) assessed by transthoracic Doppler echocardiography in the LAD coronary artery.

Main Results:

  • 86.2% of CSX patients exhibited abnormal cardiac MIBG uptake compared to none of the controls (p<0.001).
  • CSX patients had significantly lower heart/mediastinum (H/M) MIBG uptake ratio and higher defect scores than controls (p<0.001 and p=0.002, respectively).
  • Coronary flow response to both adenosine and CPT was significantly reduced in CSX patients compared to controls (p<0.001 for both).
  • No significant correlation was found between MIBG uptake parameters (H/M ratio, defect score) and CFR to adenosine or CPT in CSX patients (p>0.05 for all).

Conclusions:

  • Patients with CSX demonstrate significant abnormalities in both cardiac adrenergic nerve function and coronary microvascular function.
  • Despite the presence of both abnormalities, no direct correlation was identified between MIBG uptake defects and impaired coronary microvascular function in this CSX cohort.
  • Further research is warranted to elucidate the underlying mechanisms and the clinical significance of MIBG defects in CSX.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...